Benzinga's Stock Whisper Index: 5 Tickers Investors Secretly Monitor But Don't Talk About

Investors are on the hunt for undervalued, under followed and emerging stocks, and retail traders have countless methods at their disposal to uncover new information.

Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks each week that are just under the surface and warrant attention.

The index layers editorial commentary to help make sense of why these stocks should be of interest and whether investors and casual readers should watch them. Here is a look at the Benzinga Stock Whisper Index for the week of July 14:

Rivian Automotive (NASDAQ:RIVN) has seen shares rise over 70% in the last month. The electric vehicle company was also drawing strong interest from Benzinga readers over the last week due to its second-quarter (Q2) production and delivery numbers: 12,640 deliveries in Q2 and 13,992 vehicles produced. That's a significant jump from Q1. Several analysts subsequently raised their price targets on the stock.
Recursion Pharmaceuticals (NASDAQ:RXRX) saw shares surge this week after announcing a $50 million investment in the company by Nvidia Corporation (NASDAQ:NVDA). The clinical stage biopharmaceutical company said it would combine Nvidia’s cloud services with its AI models for drug discovery. "With our powerful dataset and NVIDIA's accelerated computing capabilities, we intend to create groundbreaking foundation models in biology and chemistry at a scale unlike anything that has ever been released in the biological space," Recursion CEO Chris Gibson said.
Dragonfly Energy Holdings Corp (NASDAQ:DFLI) has seen shares fall over 80% year-to-date in 2023. A small rally happened in shares after the lithium-ion battery company announced that nuCamp RV travel trailers and products will use Dragonfly products as its standard equipment beginning with 2024 models.
Petros Pharmaceuticals (NASDAQ:PTPI) has seen strong interest from readers for two straight weeks, earning a spot on the Stock Whisper Index. The men’s health company recently announced a $15 million private placement. In April, Petros Pharmaceuticals was the 16th most searched ticker on Benzinga Pro.
PainReform (NASDAQ:PRFX) has seen shares rise 40% year-to-date in 2023. Shares of the specialty pharmaceutical company have been extremely volatile, with the stock halted during the week. The stock, which has a low float of less than one million shares, saw volume soar above 10 million shares on Tuesday compared to an average volume of around 57,000 shares. The ticker was also trending on social media.